These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17530815

  • 1. A polysaccharide carrier to effectively deliver native phosphodiester CpG DNA to antigen-presenting cells.
    Shimada N, Coban C, Takeda Y, Mizu M, Minari J, Anada T, Torii Y, Shinkai S, Akira S, Ishii KJ, Sakurai K.
    Bioconjug Chem; 2007; 18(4):1280-6. PubMed ID: 17530815
    [Abstract] [Full Text] [Related]

  • 2. Ternary complex consisting of DNA, polycation, and a natural polysaccharide of schizophyllan to induce cellular uptake by antigen presenting cells.
    Takeda Y, Shimada N, Kaneko K, Shinkai S, Sakurai K.
    Biomacromolecules; 2007 Apr; 8(4):1178-86. PubMed ID: 17328571
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier.
    Shimada N, Ishii KJ, Takeda Y, Coban C, Torii Y, Shinkai S, Akira S, Sakurai K.
    Bioconjug Chem; 2006 Apr; 17(5):1136-40. PubMed ID: 16984120
    [Abstract] [Full Text] [Related]

  • 4. A polysaccharide carrier for immunostimulatory CpG DNAs to enhance cytokine secretion.
    Mizu M, Koumoto K, Anada T, Matsumoto T, Numata M, Shinkai S, Nagasaki T, Sakurai K.
    J Am Chem Soc; 2004 Jul 14; 126(27):8372-3. PubMed ID: 15237982
    [Abstract] [Full Text] [Related]

  • 5. Enhanced cytokine secretion from primary macrophages due to Dectin-1 mediated uptake of CpG DNA/β-1,3-glucan complex.
    Minari J, Mochizuki S, Matsuzaki T, Adachi Y, Ohno N, Sakurai K.
    Bioconjug Chem; 2011 Jan 19; 22(1):9-15. PubMed ID: 21126031
    [Abstract] [Full Text] [Related]

  • 6. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
    Mochizuki S, Morishita H, Kobiyama K, Aoshi T, Ishii KJ, Sakurai K.
    J Control Release; 2015 Dec 28; 220(Pt A):495-502. PubMed ID: 26562685
    [Abstract] [Full Text] [Related]

  • 7. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
    Yoshinaga T, Yasuda K, Ogawa Y, Nishikawa M, Takakura Y.
    Immunology; 2007 Mar 28; 120(3):295-302. PubMed ID: 17199803
    [Abstract] [Full Text] [Related]

  • 8. Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA.
    Kim D, Rhee JW, Kwon S, Sohn WJ, Lee Y, Kim DW, Kim DS, Kwon HJ.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):362-7. PubMed ID: 19103173
    [Abstract] [Full Text] [Related]

  • 9. Efficient peritoneal dissemination treatment obtained by an immunostimulatory phosphorothioate-type CpG DNA/cationic liposome complex in mice.
    Kuramoto Y, Kawakami S, Zhou S, Fukuda K, Yamashita F, Hashida M.
    J Control Release; 2008 Mar 20; 126(3):274-80. PubMed ID: 18237815
    [Abstract] [Full Text] [Related]

  • 10. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G, Flora M, Chattopadhyay G, Klinman DM, Lees A, Mond JJ, Snapper CM.
    Cell Immunol; 2004 Mar 20; 232(1-2):64-74. PubMed ID: 15922717
    [Abstract] [Full Text] [Related]

  • 11. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
    Yoshida H, Nishikawa M, Yasuda S, Mizuno Y, Toyota H, Kiyota T, Takahashi R, Takakura Y.
    J Gene Med; 2009 Aug 20; 11(8):708-17. PubMed ID: 19462411
    [Abstract] [Full Text] [Related]

  • 12. Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism.
    Anderson RB, Cianciolo GJ, Kennedy MN, Pizzo SV.
    J Leukoc Biol; 2008 Feb 20; 83(2):381-92. PubMed ID: 17967834
    [Abstract] [Full Text] [Related]

  • 13. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.
    Knuefermann P, Schwederski M, Velten M, Krings P, Ehrentraut H, Rüdiger M, Boehm O, Fink K, Dreiner U, Grohé C, Hoeft A, Baumgarten G, Koch A, Zacharowski K, Meyer R.
    Cardiovasc Res; 2008 Apr 01; 78(1):26-35. PubMed ID: 18194990
    [Abstract] [Full Text] [Related]

  • 14. Cytokine induction by a bacterial DNA-specific modified base.
    Tsuchiya H, Matsuda T, Harashima H, Kamiya H.
    Biochem Biophys Res Commun; 2005 Jan 28; 326(4):777-81. PubMed ID: 15607736
    [Abstract] [Full Text] [Related]

  • 15. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
    Haas T, Metzger J, Schmitz F, Heit A, Müller T, Latz E, Wagner H.
    Immunity; 2008 Mar 28; 28(3):315-23. PubMed ID: 18342006
    [Abstract] [Full Text] [Related]

  • 16. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
    Wilson HL, Dar A, Napper SK, Marianela Lopez A, Babiuk LA, Mutwiri GK.
    Int Rev Immunol; 2006 Mar 28; 25(3-4):183-213. PubMed ID: 16818371
    [Abstract] [Full Text] [Related]

  • 17. β-1,3-Glucan/antisense oligonucleotide complex stabilized with phosphorothioation and its gene suppression.
    Mochizuki S, Sakurai K.
    Bioorg Chem; 2010 Dec 28; 38(6):260-4. PubMed ID: 20673953
    [Abstract] [Full Text] [Related]

  • 18. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker.
    Nakamura K, Wang Y, Liu X, Kubo A, Hnatowich DJ.
    J Nucl Med; 2007 Nov 28; 48(11):1845-52. PubMed ID: 17978353
    [Abstract] [Full Text] [Related]

  • 19. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL, Tang LF, Lew FC, Wong HS, Chua YL, MacAry PA, Kemeny DM.
    J Immunol; 2009 Jul 01; 183(1):41-50. PubMed ID: 19535645
    [Abstract] [Full Text] [Related]

  • 20. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.
    Wilson KD, Raney SG, Sekirov L, Chikh G, deJong SD, Cullis PR, Tam YK.
    Int Immunopharmacol; 2007 Aug 01; 7(8):1064-75. PubMed ID: 17570323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.